Skip to main content

Table 1 Main characteristics at baseline of patients treated with primaquine at 15 or 30 mg/day for 14 days in French Guiana

From: Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison

Population characteristics

Primaquine regimen

p-value

15 mg/day, n = 283

30 mg/day, n = 261

Age (mean in years ± sd)

36.8 ± 13.5

33.8 ± 10.6

0.004

Sex ratio (male/female)

3.0

5.5

0.02

Weight (mean in kg ± sd)

71.7 ± 12.6

76.9 ± 10.4

< 0.001

Weight (range in kg)

40–119

41–130